Australia, Dec. 11 -- Australian Clinical Labs Ltd. (ACL) has reported gross short sales of 21,040 FPO shares on Dec. 9. The percent of issued capital of the company reported as short sales is 0.01 percent. The issued capital of the company is 200,753,171 shares.
Disclaimer: Curated by HT Syndication.
